2022 the Japanese Society of Medical Oncology Annual Meeting

Presentation information

Print

Mini-Oral Session

[MO12] Mini-Oral Session 12　Hematologic Malignancies 2（Lymphoid）
【E】

Thu. Feb 17, 2022 8:30 AM - 9:20 AM Room 9 (Swan, 1F, Kyoto International Conference Center)

Chair：Kenji Ishitsuka（Department of Hematology and Rheumatology, Kagoshima University），Yasushi Takamatsu（Division of Medical Oncology, Hematology and Infectious Diseases, Department of Internal medicine, Fukuoka University）

[MO12-3] Subcutaneous Epcoritamab in Relapsed/Refractory Chronic Lymphocytic Leukemia: Preliminary Results From EPCORE CLL-1

○Anthony Mato1, Jacob Haaber Christensen2, Hans Herluf Bentzen3, Carsten Utoft Niemann4, Martin Hutchings4, Jenny Chen5, Daniela Hoehn5, Marcia Rios5, Tammy Palenski6, Tommy Li5, Arnon P. Kater7 (1.Memorial Sloan Kettering Cancer Center, Chronic Lymphocytic Leukemia Program, New York, NY, USA, 2.Odense University Hospital, Odense, Denmark;, 3.Aarhus University Hospital, Aarhus, Denmark, 4.Rigshospitalet, Copenhagen, Denmark, 5.Genmab, Princeton, NJ, USA, 6.AbbVie, North Chicago, IL, USA, 7.Amsterdam UMC, Cancer Center Amsterdam, University of Amsterdam, Netherlands)

Abstract password authentication.
The password can be found on page 27 of the program book.

Password